Lupin informs about press release

17 Jun 2024 Evaluate
Lupin has enclosed a Press Release regarding the appointment of Abdelaziz Toumi as the Chief Executive Officer of the Company’s newly formed subsidiary, Lupin Manufacturing Solutions (‘LMS’). LMS is engaged in the development, manufacture and sale of Active Pharmaceutical Ingredients and is starting to build its Contract Development and Manufacturing Operations business. The above may be considered as disclosure pursuant to Regulation 30 of the Listing Regulations. The above is for information and dissemination.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2147.55 -14.65 (-0.68%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.